Document:

<PAGE>

                                                                    EXHIBIT 10.3

                   AMENDMENT NO. 4 TO NOTE PURCHASE AGREEMENT

      This Amendment No. 4 to Note Purchase Agreement (this "Amendment"), dated
as of May 12, 2004, amends that certain Note Purchase Agreement, dated as of
March 1, 2002, by and among Horizon Medical Products, Inc., a Georgia
corporation (the "Company"); ComVest Venture Partners, L.P., a Delaware limited
partnership ("ComVest," and together with its successors and assigns, the
"Purchaser"), and the Additional Note Purchasers (as defined therein), as
amended by Amendment No. 1 to Note Purchase Agreement, dated as of June 10,
2002, Amendment No. 2 to Note Purchase Agreement, dated as of July 29, 2002, and
Amendment No. 1 to Note Purchase Agreement dated as of October 21, 2003 (as
amended, the "Note Purchase Agreement"). Capitalized terms used in this
Amendment but not defined herein have the meanings given to such terms in the
Note Purchase Agreement.

      WHEREAS, the Company has requested an extension of the time to repay the
indebtedness and certain other modifications to the Note Purchase Agreement; and

      WHEREAS, the Purchaser and Medtronic, Inc. ("Medtronic") have agreed to
such modification subject to the terms and conditions set forth herein; and

      WHEREAS, the other Additional Note Purchasers have the right, but not the
obligation, to become parties to this Amendment.

      NOW, THEREFORE, in consideration of the premises and mutual covenants of
the parties hereunder, the Company, the Purchaser and the Electing Noteholders
(as defined below) agree as follows:

      Section 1. Amendments. The Note Purchase Agreement and, to the extent
applicable, the Notes are hereby modified as follows:

            (a) The definition of "Maturity Date" is hereby deleted in its
      entirety and replaced with the following:

                  ""Maturity Date" means (i) with respect to the Electing Notes,
            July 16, 2008 and (ii) with respect to the Non-Electing Notes, July
            16, 2005."

            (b) The following definitions are hereby added to Section 1 of the
      Note Purchase Agreement:

                  ""Electing Noteholders" means the Purchaser, Medtronic, and
            each Additional Note Purchaser who is a party to this Amendment."

                  ""Electing Notes" means the Purchaser Senior Subordinated
            Convertible Note, the Medtronic Additional Note, and the Additional
            Notes held by the Electing Noteholders."

<PAGE>

                  ""Medtronic Co-Marketing Agreement"" means that certain
            Co-Promotion Agreement dated as of March 15, 2002, between Medtronic
            and the Company, and as amended by that amendment thereto dated as
            of April 15, 2003.

                  ""Merger" means the Merger (as defined in the Merger
            Agreement) and the other transactions contemplated by the Merger
            Agreement."

                  ""Merger Agreement" means the Agreement and Plan of Merger,
            dated May 12, 2004, by and among RITA MEDICAL SYSTEMS, INC., a
            Delaware corporation ("Parent"), HORNET ACQUISITION CORP., a
            Delaware corporation and a wholly-owned subsidiary of Parent, and
            the Company."

                  ""Merger Closing Date" means the Closing Date as defined in
            the Merger Agreement."

                  ""Non-Electing Notes" means the Additional Notes held by the
            Additional Note Purchasers who do not execute this Amendment as
            Electing Noteholders."

            (c) Section 2.1(a) is hereby deleted in its entirety and replaced
      with the following:

            "(a)(i) The Company has duly authorized the issue, sale and delivery
            of (A) its Purchaser Senior Subordinated Convertible Note, in the
            aggregate principal amount of $4,400,000, to be dated the date of
            issue thereof, (B) its Medtronic Additional Note, in the aggregate
            principal amount of $4,000,000, to be dated the date of issue
            thereof and (C) its Additional Notes, in the aggregate principal
            amount of up to $6,600,000, to be dated the date of issue thereof.

            (ii) Each of the Electing Notes shall bear interest from such date
            on the unpaid principal amount thereof (calculated on the basis of a
            360-day year and actual days elapsed) at a rate per annum equal to
            (A) 6% per annum from the date thereof to and including the date
            that is the six month anniversary of the Closing Date, (B) 8% per
            annum from the date that is the six month anniversary of the Closing
            Date until the first anniversary of the Merger Closing Date, and (C)
            14% from the first anniversary of the Merger Closing Date until such
            time as the Electing Notes shall have been paid in full, such
            interest to be payable quarterly in arrears on the fifth day of each
            month (commencing on the date that is the three month anniversary of
            the Closing Date), and at maturity, to bear interest, payable on
            demand, on any overdue principal and, to the extent permitted by
            applicable law, on any overdue interest, fees and other overdue
            amounts payable hereunder until the same shall be paid, at a
            variable rate per
<PAGE>

            annum equal to the sum of 3.00% plus the rate that would at the time
            be applicable under the foregoing provisions to principal amounts
            not overdue and, in the case of each of the Electing Notes, to
            mature on the Maturity Date, and to be substantially in the form of
            Exhibit B hereto;

            (iii) Each of the Non-Electing Notes shall bear interest from such
            date on the unpaid principal amount thereof (calculated on the basis
            of a 360-day year and actual days elapsed) at a rate per annum equal
            to (A) 6% per annum from the date thereof to and including the date
            that is the six month anniversary of the Closing Date and (B) 8% per
            annum from the date that is the six month anniversary of the Closing
            Date until such time as the Non-Electing Notes shall have been paid
            in full, such interest to be payable quarterly in arrears on the
            fifth day of each month (commencing on the date that is the three
            month anniversary of the Closing Date), and at maturity, to bear
            interest, payable on demand, on any overdue principal and, to the
            extent permitted by applicable law, on any overdue interest, fees
            and other overdue amounts payable hereunder until the same shall be
            paid, at a variable rate per annum equal to the sum of 3.00% plus
            the rate that would at the time be applicable under the foregoing
            provisions to principal amounts not overdue and, in the case of each
            of the Non-Electing Notes, to mature on the Maturity Date, and to be
            substantially in the form of Exhibit B hereto;"

            (d) Section 3.1(a) is hereby deleted in its entirety and replaced
      with the following:

            "(a) Subject to the provisions of this Section 3.1(a), the Company
            at its option may, after giving not less than three (3) days' prior
            written notice (the "Company Conversion Notice") to the Purchaser
            and each Additional Note Purchaser, prepay the unpaid principal
            balance of the Notes, together with all accrued but unpaid interest
            on the principal amount being prepaid to the date of such
            prepayment, in whole or in part (in an aggregate amount of not less
            than $1,000,000 or any greater amount which is an even multiple of
            $100,000, or in an amount equal to the aggregate principal balance
            of all of the Notes) as set forth below. It is also expressly
            understood and agreed by the Company that, notwithstanding anything
            to the contrary contained herein or in any other Note Document, each
            holder of a Note shall have the right to convert such Note as
            provided in this Agreement notwithstanding the giving by the Company
            of any 3-day notice of prepayment under this Section 3.1(a) if such
            holder of a Note shall give to the Company the Company Conversion
            Notice or the Default Conversion Notice, as the case may be."

            (e) The following Section 11.5 is hereby added to the Note Purchase
            Agreement:

            "Section 11.5. Estoppel.

<PAGE>

            (a) The Requisite Noteholders, on behalf of themselves and the
            Additional Note Purchasers, hereby acknowledge and agree that, as of
            May 12, 2004: (i) this Agreement and all covenants, rights and
            obligations contained herein are in full force and effect; (ii) to
            their knowledge, no breach or default on the part of the Company
            exists under this Agreement or the Notes; and (iii) to their
            knowledge, no event has occurred and no condition exists which, with
            the giving of notice or lapse of time or both, could constitute such
            a default or would otherwise entitle any party to this Agreement or
            the holder of any of the Notes to declare any breach or default
            under the Agreement, including without limitation any event or
            condition that constitutes or could constitute an Event of Default,
            on the part of the Company. The Requisite Noteholders further
            acknowledge and agree, on behalf of themselves and the Additional
            Note Purchasers, that the statements set forth in this Section 11.5
            shall act as a waiver of any claim by any party to this Agreement or
            the holder of any of the Notes, to the extent such claim is based
            upon facts contrary to those asserted in this Section 11.5.

            (b) Notwithstanding any provision in this Agreement to the contrary,
            neither Medtronic nor the Requisite Noteholders shall be permitted
            to declare an Event of Default under Section 11.1 of this Agreement
            in respect of any breach, default or condition that occurs or exists
            prior to the expiration of the Pre-Closing Period, unless such
            breach, default or condition giving rise to such Event of Default,
            either alone or together with any other breach, default or condition
            giving rise to any other Event of Default, has, or is reasonably
            likely to have, a Material Adverse Effect. For purposes of this
            Section 11.5(b), "Pre-Closing Period" means the period beginning on
            May 12, 2004 and ending immediately before the Effective Time (as
            defined in the Merger Agreement)."

      Section 2. Merger Consent. Notwithstanding any provision in the Note
Purchase Agreement to the contrary, including, without limitation, Sections 9.8,
10.3 and 11.1, ComVest and Medtronic, representing the Requisite Noteholders,
hereby consent to the Merger and acknowledge that neither the Merger nor any of
the transactions contemplated in the Merger Agreement will constitute an Event
of Default under the Note Purchase Agreement.

      Section 3. Effective Date. This Amendment will become effective as to the
Purchaser, Medtronic and each other Electing Noteholder as of the Effective Time
(as defined in the Merger Agreement); provided, however, that the amendments set
forth in Section 1(e) above shall be effective as of the date hereof.

      Section 4. Continuing Effect. Except as expressly amended hereby, the Note
Purchase Agreement, the Notes and the Additional Notes shall continue to be, and
shall remain, in full force and effect in accordance with its terms.

      Section 5. Governing Law. This Amendment shall be governed by and
construed and interpreted in accordance with the laws of the State of New York.

<PAGE>

      Section 6. Counterparts. This Amendment may be executed in two or more
counterparts, each of which shall be deemed an original but all of which shall
together constitute one and the same instrument.

                            [SIGNATURE PAGES FOLLOW]

<PAGE>

         IN WITNESS WHEREOF, the undersigned parties have caused this Amendment
to be duly executed by their respective officers thereunto duly authorized, as
of the date first above written.

                                     COMPANY

                                     HORIZON MEDICAL PRODUCTS, INC.

                                     By: /s/  Robert J. Wenzel
                                         --------------------------
                                        Name:  Robert J. Wenzel
                                        Title: Interim CEO

                                     PURCHASER

                                     COMVEST VENTURE PARTNERS, L.P.

                                     By: /s/ Harold Blue
                                         --------------------------
                                        Name:  Harold Blue
                                        Title: Partner/President

                                     MEDTRONIC

                                     MEDTRONIC, INC.

                                     By: /s/ Michael D. Ellwein
                                         ------------------------------
                                        Name:  Michael D. Ellwein
                                        Title: Vice President and Chief
                                                 Development Officer

<PAGE>

                                     ELECTING NOTEHOLDERS

                                     [INSERT SIGNATURE BLOCKS FOR ELECTING
                                     NOTEHOLDERS]<PAGE>

                                                                    EXHIBIT 10.4

                         HORIZON MEDICAL PRODUCTS, INC.
                     AMENDMENT NO. 1 TO AMENDED AND RESTATED
                            SECURITYHOLDERS AGREEMENT

This Amendment No. 1 to Amended and Restated Securityholders Agreement (this
"Amendment") is entered into as of May 12, 2004, by and among Horizon Medical
Products, Inc., a Georgia corporation (the "Company"), ComVest Venture Partners,
L.P., a Delaware limited partnership ("ComVest"), Medtronic, Inc., a Minnesota
corporation ("Medtronic" and, together with ComVest, each, an "Investor," and,
together, the "Investors"), and Marshall Hunt (a "Major Stockholder" and,
together with the Investors, the "Company Stockholders").

                                   BACKGROUND

      A. The Company, the Company Stockholders and Standard Federal Bank
National Association, a national banking association, acting by and through
LaSalle Business Credit, Inc., a Delaware corporation, are parties to that
certain Amended and Restated Securityholders Agreement, dated as of October 21,
2003 (the "Agreement"). Capitalized terms used herein without definition shall
have the meanings ascribed to them in the Agreement.

      B. The Company, RITA Medical Systems, Inc., a Delaware corporation
("Parent"), and Hornet Acquisition Corp., a Delaware corporation and
wholly-owned subsidiary of Parent ("Merger Sub"), have entered into an Agreement
and Plan of Merger, dated as of May __, 2004 (the "Merger Agreement"), which
provides for the merger of Merger Sub with and into the Company (the "Merger"),
pursuant to which the Company shall become a wholly-owned subsidiary of Parent.

      C. Pursuant to Section 6.6 of the Agreement, the Agreement may be amended
in any manner with the written consent of the record or beneficial holders of at
least eighty percent (80%) of the Registrable Securities held by the Holders and
the Company, when authorized by resolution of its Board of Directors.

      D. The termination of the Agreement as of the Effective Time is a
condition to the obligation of Parent and Merger Sub to consummate the
transactions contemplated by the Merger Agreement.

      E. As a condition and inducement to the willingness of Parent and Merger
Sub to consummate the transactions contemplated by the Merger Agreement, the
parties hereto desire to amend the Agreement as set forth herein.

                                    AMENDMENT

      1. Termination. The following Section 6.14 is hereby added to the
Agreement:

            "6.14 Notwithstanding anything in the this Agreement to the
      contrary, this Agreement shall terminate and be of no further force and
      effect immediately before the Effective Time of the Merger, pursuant the
      Merger. For purposes of this Agreement, "Effective Time" shall have the
      meaning ascribed to it in the Merger Agreement."

<PAGE>

      2. Consent. Notwithstanding any provision in the Agreement to the
contrary, including, without limitation, Sections 3 and 5.6, ComVest and
Medtronic hereby consent to the Major Stockholder's entering into the agreements
and the transactions contemplated by the Merger Agreement, including, without
limitation, the Voting Agreement and the Lock Up Agreement (as such terms are
defined in the Merger Agreement). ComVest and Medtronic hereby waive any
provision of the Agreement which may be in conflict with any action taken or
agreement signed by the Major Stockholder in connection with the Merger, and
ComVest and Medtronic acknowledge that no such action or agreement will
constitute an Event of Default under the Agreement.

      3. Miscellaneous.

            3.1 Full Force and Effect. Except as expressly amended hereby, the
Agreement shall continue in full force and effect in accordance with the
provisions thereof on the date hereof.

            3.2 Counterparts. This Amendment may be signed in one or more
counterparts, all of which shall be considered one and the same instrument.

                            [signature page follows]

                                       2

<PAGE>

      IN WITNESS WHEREOF, the Company and the Company Stockholders have caused
this Amendment to be duly executed as of the day and year first above written.

HORIZON MEDICAL PRODUCTS, INC.

By: /s/ Robert J. Wenzel
    ----------------------------------

Name: Robert J. Wenzel
      --------------------------------

Title: Interim CEO
       -------------------------------

COMVEST VENTURE PARTNERS, L.P.

By: /s/ Harold Blue
    ----------------------------------
Name: Harold Blue
      --------------------------------
Title: Partner/President
       -------------------------------
MEDTRONIC, INC.

By: /s/ Michael D. Ellwein
       -------------------------------
Name: Michael D. Ellwein
       -------------------------------
Title: Vice President and Chief
       Development Officer
       -------------------------------

MAJOR STOCKHOLDER

/s/ Marshall Hunt
--------------------------------------
Marshall Hunt

                      SIGNATURE PAGE TO AMENDMENT NO. 1 TO
                            SECURITYHOLDERS AGREEMENT

                                       3

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00066-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00066-of-00352.parquet"}]]